COR

Robert P. Mauch

Known title: Executive Vice PresidentCIK: 0001633897

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Cencora Valuation and AI Impact: Analysts Debate Growth Prospects. Recent analyses debate whether Cencora is undervalued or if its raised guidance is already priced in, as the stock trades near its 52-week high and average analyst target. Other reports suggest the company's distribution model could benefit more from AI disruption than certain telehealth competitors. The stock is also compared to major pharmaceutical companies like AbbVie and Eli Lilly as market participants assess the healthcare sector.

this person other insiders at COR

Transaction History

COR▲ Buy$324K
COR▼ Sell$1.4M
COR▼ Sell$479K
COR▼ Sell$1.8M
COR▲ Buy$324K
COR▲ Buy$324K
COR▼ Sell$1.8M
COR▼ Sell$0
COR▲ Buy—
COR▼ Sell$224K
COR▲ Buy—
COR▼ Sell$776K
COR▼ Sell$1.9M
COR▲ Buy$324K
COR▼ Sell$5.8M
COR▲ Buy$0
COR▼ Sell$603K
COR▲ Buy—
COR▼ Sell$626K
COR▲ Buy—
COR▼ Sell$1.7M
COR▲ Buy$324K
COR▲ Buy$324K
COR▼ Sell$1.5M
COR▼ Sell$1.5M
COR▲ Buy$278K
COR▲ Buy$278K
COR▼ Sell$1.5M
COR▲ Buy$278K
COR▼ Sell$1.5M
COR▼ Sell$1.4M
COR▲ Buy$278K
COR▲ Buy$278K
COR▼ Sell$1.4M
COR▲ Buy$278K
COR▼ Sell$842K
COR▼ Sell$455K
COR▼ Sell$445K
COR▲ Buy$278K
COR▼ Sell$823K
COR▲ Buy—
COR▼ Sell$183K
COR▲ Buy$0
COR▼ Sell$3.8M
COR▲ Buy—
COR▼ Sell$401K
COR▲ Buy—
COR▼ Sell$431K
COR▼ Sell$366K
COR▲ Buy—
COR▲ Buy$3.0M
COR▼ Sell$13.5M
COR▲ Buy—
COR▼ Sell$99K
COR▼ Sell$344K
COR▲ Buy—
COR▲ Buy—
COR▼ Sell$319K
COR▲ Buy—
COR▲ Buy—
COR▼ Sell$300K
COR▼ Sell$2.2M
COR▼ Sell$3.7M
COR▲ Buy—
COR▼ Sell$84K
COR▲ Buy—
COR▼ Sell$387K
COR▲ Buy—
COR▼ Sell$269K
COR▲ Buy—
COR▼ Sell$250K
COR▲ Buy—
COR▼ Sell$1.7M
COR▼ Sell$3.5M
COR▲ Buy$3.4M
COR▼ Sell$6.1M
COR▲ Buy—
COR▼ Sell$1.2M
COR▲ Buy—
COR▲ Buy—
COR▼ Sell$218K
COR▲ Buy$4.0M
COR▼ Sell$5.2M

We use analytics to understand how market-wall is used. No personal data is sold.